LEXINGTON, Mass., Sept. 19, 2017 /PRNewswire/ -- Agenus Inc.
(NASDAQ: AGEN), an immune-oncology company with a pipeline of
immune checkpoint antibodies and cancer vaccines, announced today
that members of the Company's Leadership will present and host
one-on-one meetings at two healthcare investment conferences in
September. The details for the conferences are:
- Garo Armen, PhD, Chairman and
CEO of Agenus, and Jennifer Buell,
PhD, Chief Communications and External Affairs Officer will present
at the Cantor Fitzgerald Global Healthcare Conference on
September 25 at the InterContinental
Barclay Hotel in New York.
Corporate presentation at 4:10 p.m.
ET.
- Michael Plater, PhD, Chief
Business Officer, and Jennifer
Buell, PhD, Chief Communications and External Affairs
Officer will present at the Ladenburg Thalman 2017 Healthcare
Conference on September 26 at the
Sofitel Hotel in New York.
Corporate presentation at 1 p.m.
ET.
A live audio webcast will be available on the "Events &
Presentations" section of the Company's investor website at
www.agenusbio.com where a replay will also be available following
the presentation.
About Agenus
Agenus is a clinical-stage immuno-oncology company focused on
the discovery and development of therapies that engage the body's
immune system to fight cancer. The Company's vision is to expand
the patient populations benefiting from cancer immunotherapy by
pursuing a number of combination approaches that leverage a broad
repertoire of antibody therapeutics and proprietary cancer vaccine
platforms. The Company is equipped with a suite of antibody
discovery platforms and a state-of-the-art GMP manufacturing
facility with the capacity to support early phase clinical
programs. Agenus is headquartered in Lexington, MA. For
more information, please visit www.agenusbio.com; information that
may be important to investors will be routinely posted on our
website.
Contact:
Agenus Inc.
Jennifer Buell, PhD
781-674-4420
Jennifer.Buell@agenusbio.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/agenus-to-present-at-two-healthcare-investor-conferences-in-september-300521712.html
SOURCE Agenus Inc.